Yes, Dexcom G6 and Dexcom G7 are covered for eligible Nova Scotians aged 2 years and older who have type 1 or type 2 diabetes and manage it with intensive insulin therapy.

Intensive insulin therapy is insulin pump therapy or multiple daily injections. Multiple daily injections of insulin are defined as one (or more) injection(s) of basal insulin and three (or more) injections of bolus insulin, with a minimum of at least four total insulin injections per day.

Coverage for Dexcom CGM products is provided through two publicly funded programs in Nova Scotia: 

• Existing Nova Scotia Pharmacare programs: Coverage for eligible residents who are registered clients of Seniors Pharmacare, Community Services Pharmacare, or Family Pharmacare program These Pharmacare Programs may have deductibles, premiums, and/or copayments.
   
• New Sensor-based Glucose Monitoring (SBGM) program: Universal supplemental coverage for eligible residents, with upfront deductibles based on your adjusted annual family income.  You will pay the full cost of the CGM supplies at the pharmacy until you reach your deductible, after which the program will pay the cost until the end of the program year. Note: The Program is the payer of last resort, meaning your private insurance would be the first to pay any claim.

Anyone who meets eligibility criteria for coverage of Dexcom CGM supplies can choose which program works best for their individual or financial circumstances.